Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1170-1173 (24 May), doi:10.1136/bmj.39504.506319.80
Gordon H Guyatt, professor1, Andrew D Oxman, researcher2, Regina Kunz, associate professor3, Roman Jaeschke, clinical professor4, Mark Helfand, professor of medicine5, Alessandro Liberati, professor6, Gunn E Vist, researcher2, Holger J Schünemann, associate professor7, for the GRADE working group
1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada L8N 3Z5, 2 Norwegian Knowledge Centre for the Health Services, PO Box 7004, 0130 Oslo, Norway, 3 Basel Institute of Clinical Epidemiology, University Hospital Basel, 4031 Basel, Switzerland, 4 Department of Medicine, McMaster University, Hamilton, ON, Canada L8N 3Z5, 5 Portland VA Medical Center and OHSU Department of Medicine, Portland, Oregon 97201, 6 Università di Modena e Reggio Emilia and Agenzia Sanitaria Regionale, Regione Emilia Romagna, 40127 Bologna, Italy, 7 Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy
Correspondence to: G H Guyatt guyatt@mcmaster.ca
Guideline panellists have differing opinions on whether resource use should influence decisions on individual patients. As medical care costs rise, resource use considerations become more compelling, but panellists may find dealing with such considerations challenging
| The first 150 words of the full text of this article appear below. |
In this last part of a series describing the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to making recommendations we will look at how guideline panellists and clinicians can incorporate matters related to the use of resources into recommendations and practice. Clinical recommendations inevitably involve judgments about the allocation of resources, judgments commonly referred to as costs. We will deal with some of the challenges of considering costs, explain reasons for focusing on resource use rather than costs, and discuss how to incorporate considerations of resource use into recommendations.
In one sense, cost is just another potentially important outcome—like mortality, morbidity, and quality of life—associated with alternative ways of managing patients. In addition to these clinical outcomes, an intervention may increase costs or decrease costs. However, costs differ from other outcomes in several ways (box).1
|
Read all Rapid Responses